<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Br J Cancer</journal-id><journal-title>British Journal of Cancer</journal-title><issn pub-type="ppub">0007-0920</issn><issn pub-type="epub">1532-1827</issn><publisher><publisher-name>Nature Publishing Group|1</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">9744511</article-id><article-id pub-id-type="pmc">2063048</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Randomized study of chemotherapy and surgery versus radiotherapy for stage IIIA non-small-cell lung cancer: a National Cancer Institute of Canada Clinical Trials Group Study.</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Shepherd</surname><given-names>F. A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Johnston</surname><given-names>M. R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Payne</surname><given-names>D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Burkes</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Deslauriers</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Cormier</surname><given-names>Y.</given-names></name></contrib><contrib contrib-type="author"><name><surname>de Bedoya</surname><given-names>L. D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ottaway</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>James</surname><given-names>K.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Zee</surname><given-names>B.</given-names></name></contrib></contrib-group><aff>Interdepartmental Division of Oncology of the University of Toronto, Ontario, Canada.</aff><pub-date pub-type="ppub"><month>9</month><year>1998</year></pub-date><volume>78</volume><issue>5</issue><fpage>683</fpage><lpage>685</lpage><abstract><p><offsets xml_i="2247" xml_f="2783" txt_i="11" txt_f="547">Thirty-one patients with stage IIIA (N2) non-small-cell lung cancer were randomized to receive radiotherapy alone or chemotherapy with cisplatin and vinblastine followed by surgery. Response rates to induction chemotherapy and radiotherapy were 50% and 53.3% respectively. Complete surgical resection was possible for 62.5% of patients. Median survival times were 16.2 and 18.7 months for radiotherapy alone and chemotherapy-surgery respectively (P = Ns), with no long-term improvement in survival seen with combined-modality treatment.</offsets></p></abstract></article-meta></front><body><supplementary-material content-type="scanned-pages"><graphic xlink:href="brjcancer00005-0127.tif" xlink:title="scanned-page" xlink:role="683" mimetype="image" mime-subtype="tiff"></graphic><graphic xlink:href="brjcancer00005-0128.tif" xlink:title="scanned-page" xlink:role="684" mimetype="image" mime-subtype="tiff"></graphic><graphic xlink:href="brjcancer00005-0129.tif" xlink:title="scanned-page" xlink:role="685" mimetype="image" mime-subtype="tiff"></graphic></supplementary-material></body></article>